infect
novel
coronaviru
found
wuhan
china
rapidli
spread
incid
rate
increas
worldwid
due
lack
effect
treatment
option
variou
strategi
test
china
includ
drug
repurpos
studi
use
pretrain
deep
learningbas
drugtarget
interact
model
call
molecul
transformerdrug
target
interact
mtdti
identifi
commerci
avail
drug
could
act
viral
protein
result
show
atazanavir
antiretrovir
medic
use
treat
prevent
human
immunodefici
viru
hiv
best
chemic
compound
show
inhibitori
potenc
kd
nm
proteinas
follow
remdesivir
nm
efavirenz
nm
ritonavir
nm
dolutegravir
nm
interestingli
lopinavir
ritonavir
darunavir
design
target
viral
proteinas
howev
predict
may
also
bind
replic
complex
compon
inhibitori
potenc
kd
nm
addit
also
found
sever
antivir
agent
kaletra
lopinavirritonavir
could
use
treatment
overal
suggest
list
antivir
drug
identifi
mtdti
model
consid
establish
effect
treatment
strategi
coronavirus
cov
belong
famili
coronavirida
positivesens
envelop
rna
virus
caus
infect
bird
mammal
human
famili
includ
four
genera
alphacoronaviru
betacoronaviru
deltacoronaviru
gammacoronaviru
two
infam
infecti
coronavirus
genu
betacoronaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
infect
peopl
around
world
past
two
decad
unfortun
incid
accompani
high
mortal
rate
sarscov
merscov
indic
urgent
need
effect
treatment
begin
outbreak
prevent
spread
howev
achiev
current
drug
develop
applic
system
take
sever
year
newli
develop
drug
come
market
unexpectedli
world
face
situat
previou
outbreak
due
recent
epidem
atyp
pneumonia
design
coronaviru
diseas
covid
caus
novel
coronaviru
sever
acut
respiratori
syndrom
coronaviru
wuhan
china
belong
betacoronaviru
contain
positivesens
singlestrand
rna
ssrna
genom
bp
contain
gene
encod
proteinas
rnadepend
rna
polymeras
rdrp
methyltransferas
spike
protein
envelop
protein
nucleocapsid
phosphoprotein
sever
unknown
protein
accord
genom
sequenc
data
http
typic
clinic
symptom
fever
dri
cough
fatigu
within
day
latenc
averag
infect
rel
slower
sever
acut
respiratori
syndrom
sar
caus
sarscov
life
cycl
coronavirus
viru
replic
via
follow
process
enter
host
cell
translat
genom
rna
grna
proteolysi
translat
polyprotein
viral
proteinas
replic
grna
viral
replic
complex
consist
rnadepend
rna
polymeras
rdrp
helicas
exonucleas
endornas
methyltransferas
assembl
viral
compon
replicationassoci
protein
primari
target
postentri
treatment
drug
suppress
viral
replic
although
much
intens
effort
made
worldwid
develop
drug
vaccin
patient
current
suffer
expect
benefit
due
slow
develop
process
novel
drug
vaccin
thu
rapid
drug
applic
strategi
immedi
appli
patient
necessari
current
way
address
matter
repurpos
commerci
avail
drug
pathogen
socal
drugrepurpos
howev
theori
artifici
intellig
ai
base
architectur
must
taken
account
order
accur
predict
drugtarget
interact
dti
enorm
amount
complex
inform
eg
hydrophob
interact
ionic
interact
hydrogen
bond
andor
van
der
waal
forc
molecul
end
previous
develop
deep
learningbas
drugtarget
interact
predict
model
call
molecul
transformerdrug
target
interact
mtdti
studi
appli
pretrain
mtdti
model
identifi
commerci
avail
antivir
drug
could
potenti
disrupt
viral
compon
proteinas
rnadepend
rna
polymeras
andor
helicas
sinc
model
util
simplifi
molecularinput
lineentri
system
smile
string
amino
acid
aa
sequenc
string
input
possibl
quickli
appli
target
protein
experiment
confirm
crystal
structur
viral
protein
share
list
top
commerci
avail
antivir
drug
could
potenti
hinder
multipl
cycl
hope
effect
drug
develop
base
aipropos
drug
candid
act
amino
acid
sequenc
proteinas
access
rnadepend
rna
polymeras
access
helicas
access
exonucleas
access
endornas
access
methyltransferas
access
replic
complex
extract
whole
genom
sequenc
access
nation
center
biotechnolog
inform
ncbi
databas
molecul
transformerdrug
target
interact
mtdti
use
predict
bind
affin
valu
commerci
avail
antivir
drug
target
protein
mtdti
base
selfattent
mechan
show
remark
success
natur
languag
process
nlp
literatur
mtdti
inspir
idea
chemist
understand
molecul
sequenc
analog
understand
languag
appli
nlp
model
drugtarget
interact
dti
task
mtdti
pretrain
chemic
languag
repres
smile
approxim
compound
similar
nlp
model
success
extract
complex
pattern
word
sequenc
mtdti
success
find
use
inform
dti
task
therefor
show
best
perform
robust
result
divers
dti
dataset
accord
previou
studi
train
model
drug
target
common
dtc
databas
bindingdb
databas
manual
curat
combin
three
type
efficaci
valu
ki
kd
integr
consistencescorebas
averag
algorithm
make
pearson
correl
score
term
ki
kd
sinc
bindingdb
databas
includ
wide
varieti
speci
target
protein
mtdti
model
potenti
power
predict
interact
antivir
drug
protein
mtdti
predict
raw
predict
result
screen
antivir
drug
fda
approv
target
viral
protein
kd
valu
less
nm
smile
contain
salt
form
exclud
final
result
predict
focus
pair
singl
molecul
target
protein
addit
remdesivir
also
incopr
analysi
therapeut
potenti
recent
suggest
wang
et
al
gliead
scienc
announc
http
autodock
vina
version
molecular
dock
virtual
screen
applic
use
predict
bind
affin
kcalmol
proteinas
fdaapprov
drug
smile
fdaapprov
drug
convert
pdbqt
format
use
open
babel
version
follow
option
p
hydrogen
ad
proteinas
model
use
mgltool
version
bind
affin
protein
fdaapprov
drug
calcul
use
autodock
vina
exhaust
paramet
set
identifi
potent
fdaapprov
drug
may
inhibit
function
core
protein
use
mtdti
deep
learningbas
model
accur
predict
bind
affin
base
chemic
sequenc
smile
amino
acid
sequenc
fasta
target
protein
without
structur
inform
deep
learningbas
approach
particularli
use
sinc
requir
protein
structur
inform
bottleneck
identifi
drug
target
uncharacter
protein
tradit
threedimension
structurebas
dock
approach
neverthless
mtdti
show
best
perform
compar
deep
learningbas
deepdta
approach
two
tradit
machin
learningbas
algorithm
simboost
kronrl
kiba
davi
data
set
take
advantag
sequencebas
drugtarget
affin
predict
approach
bind
affin
fdaapprov
drug
proteinas
rdrp
helicas
exonucleas
endornas
methyltransferas
predict
confirm
perform
mtdti
least
silico
compar
bind
affin
fdaapprov
drug
predict
mtdti
estim
autodock
vina
wide
use
structurebas
dock
algorithm
possibl
sinc
structur
proteinas
protein
recent
unveil
xray
crystallographi
pdbid
signific
neg
correl
mean
result
algorithm
show
moder
similar
higher
better
mtdti
wherea
lower
better
autodock
vina
observ
antivir
drug
dataset
r
pvalu
fdaapprov
drug
dataset
r
pvalu
fig
possibl
determin
algorithm
reliabl
without
variou
experiment
evalu
previou
studi
show
mtdti
model
one
best
deep
learningbas
model
predict
bind
affin
given
protein
compound
therefor
appli
mtdti
model
repurpos
fdaapprov
drug
potenti
inhibit
key
protein
proteinas
predict
bind
atazanavir
kd
nm
follow
remdesivir
efavirenz
ritonavir
antivir
drug
predict
affin
kd
nm
potenc
tabl
proteas
inhibitor
antivir
drug
found
kd
nm
rang
although
realworld
evid
whether
drug
act
predict
yet
case
studi
identifi
exampl
dock
studi
lopinavir
along
hiv
proteinas
inhibitor
cov
proteinas
pdbid
suggest
atazanavir
ritonavir
list
present
predict
result
may
inhibit
cov
proteinas
line
inhibitori
potenc
lopinavir
accord
predict
viral
proteinasetarget
drug
predict
act
favor
viral
replic
process
viral
proteinas
dti
model
tabl
result
includ
antivir
drug
proteinas
inhibitor
guanosin
analogu
eg
acyclovir
ganciclovir
penciclovir
revers
transcriptas
inhibitor
integras
inhibitor
among
predict
result
atazanavir
predict
potenti
bind
affin
bind
rnadepend
rna
polymeras
kd
nm
helicas
kd
nm
exonucleas
kd
nm
methyltransferas
kd
nm
endornas
kd
nm
suggest
subunit
replic
complex
may
inhibit
simultan
atazanavir
tabl
also
ganciclovir
predict
bind
three
subunit
replic
complex
rnadepend
rna
polymeras
kd
nm
exonucleas
kd
nm
rna
helicas
kd
nm
lopinavir
ritonavir
activ
materi
abbvi
kaletra
predict
potenti
affin
helicas
tabl
suggest
potenti
mer
therapeut
recent
approxim
million
worth
kaletra
dose
donat
china
previou
clinic
studi
sar
chu
et
al
may
support
decis
anoth
antihiv
drug
prezcobix
johnson
johnson
consist
darunavir
cobicistat
sent
china
darunavir
also
predict
kd
nm
helicas
tabl
howev
current
support
literatur
found
darunavir
use
cov
therapeut
although
remdesivir
fda
approv
drug
predict
potenc
result
follow
rnadepend
rna
polymeras
kd
mani
case
dti
predict
model
serv
tool
repurpos
drug
develop
novel
usag
exist
drug
applic
dti
predict
present
studi
may
use
control
unexpect
rapidli
spread
infect
sarscov
middl
east
respiratori
syndrom
merscov
frontlin
diseas
control
better
therapeut
measur
develop
sever
recent
studi
identifi
promis
drug
candid
may
help
reduc
symptom
inhibit
aspect
exampl
remdesivir
chloroquin
show
inhibitori
effect
vitro
anoth
invitro
studi
show
hydroxychloroquin
found
potent
chloroquin
inhibit
remdesivir
lopinavirritonavir
kaletra
also
reduc
pneumoniaassoci
symptom
patient
howev
studi
base
previou
knowledg
drug
show
inhibitori
effect
similar
coronavirus
sarscov
andor
merscov
contrast
approach
truli
base
pretrain
mtdti
deeplearn
model
understand
drugtarget
interact
without
domain
knowledg
fact
mtdti
success
identifi
epiderm
growth
factor
receptor
egfr
target
drug
use
clinic
predict
candid
among
chemic
compound
regist
drugbank
databas
previou
studi
suggest
structur
inform
protein
andor
molecul
necessarili
requir
predict
drugtarget
interact
result
show
follow
intrigu
find
need
test
experiment
clinic
near
futur
first
mtdti
gener
show
similar
result
overal
compar
convent
structurebas
predict
model
autodock
vina
differ
observ
exampl
atazanavir
remdesivir
efavirenz
top
three
predict
drug
may
bind
proteinas
saquinavir
nelfinavir
grazoprevir
top
three
drug
identifi
autodock
vina
fig
secondli
search
space
expand
fdaapprov
drug
immunosuppress
drug
rapamycin
everolimu
drug
tiotropium
bromid
asthma
chronic
obstruct
pulmonari
diseas
copd
identifi
promis
candid
mtdti
contrast
autodock
vina
predict
purmorphanim
lumacaftor
verrucarin
top
three
drug
could
bind
proteinas
howev
current
support
evid
drug
may
effect
inhibit
lastli
atazanavir
appear
effect
treatment
show
overal
high
bind
affin
among
test
antivir
six
protein
includ
proteinas
replic
complex
compon
tabl
predict
also
need
valid
vitro
vivo
wide
rang
clinic
trial
efficaci
safeti
hope
predict
result
may
support
experiment
therapeut
option
china
countri
suffer
pandem
align
recent
clinic
trial
beck
br
choi
park
employ
compani
deargen
inc
shin
b
employ
deargen
inc
parttim
advisor
kang
k
one
cofound
sharehold
deargen
inc
comparison
mtdti
autodock
vina
result
known
fdaapprov
antivir
drug
left
fdaapprov
drug
right
evalu
mean
mtdti
deep
learningbas
affin
score
higher
better
autodock
vina
dock
score
lower
better
remdesivir
fdaapprov
drug
regard
promis
antivir
drug
includ
analysi
tabl
drugtarget
interact
dti
predict
result
antivir
drug
avail
market
novel
coronaviru
ncbi
refer
sequenc
rnadepend
rna
polymeras
access
indic
isomer
form
smile
